GL1X · GenesisL1 explorer

UniProt W5ZZF5

Spike glycoprotein (W5ZZF5)

Spike glycoprotein (UniProt W5ZZF5): 20 experimental structures on GenesisL1, 1 ligand bound, 170 pockets. Binding sites, pockets, druggability and 3D structures in GL1X.

UniProt
W5ZZF5
Protein
Spike glycoprotein
Experimental structures
20
Predicted models
0
Ligands
1
Pockets
170 · 9 records with a druggable one

Structures

20 records of W5ZZF5 in the MolNFT archive: 20 experimental, 0 predicted.

EntryTitleMethodChainsLigandsPockets
5W9HMERS S ectodomain trimer in complex with variable domain of neutralizing antibody G4electron microscopyA, D, G, p, q, rNAG19 (best 0.87)
5W9HMERS S ectodomain trimer in complex with variable domain of neutralizing antibody G4electron microscopyA, D, G, p, q, rNAG—
5W9IMERS S ectodomain trimer in complex with variable domain of neutralizing antibody G4electron microscopyA, B, E, F, I, JNAG—
5W9IMERS S ectodomain trimer in complex with variable domain of neutralizing antibody G4electron microscopyA, B, E, F, I, JNAG—
5W9JMERS S ectodomain trimer in complex with variable domain of neutralizing antibody G4electron microscopyD, A, G, J, K, L—17 (best 0.88)
5W9JMERS S ectodomain trimer in complex with variable domain of neutralizing antibody G4electron microscopyD, A, G, J, K, L——
5W9KMERS S ectodomain trimer in complex with variable domain of neutralizing antibody G4electron microscopyA, D, G, J, K, L—20 (best 0.87)
5W9KMERS S ectodomain trimer in complex with variable domain of neutralizing antibody G4electron microscopyA, D, G, J, K, L——
5W9LMERS S ectodomain trimer in complex with variable domain of neutralizing antibody G4electron microscopyA, D, G, B, C, J—19 (best 0.87)
5W9LMERS S ectodomain trimer in complex with variable domain of neutralizing antibody G4electron microscopyA, D, G, B, C, J——
5W9MMERS S ectodomain trimer in complex with variable domain of neutralizing antibody G4electron microscopyA, D, G, E, F, J—19 (best 0.87)
5W9MMERS S ectodomain trimer in complex with variable domain of neutralizing antibody G4electron microscopyA, D, G, E, F, J——
5W9NMERS S ectodomain trimer in complex with variable domain of neutralizing antibody G4electron microscopyA, D, G, H, I, J—19 (best 0.85)
5W9NMERS S ectodomain trimer in complex with variable domain of neutralizing antibody G4electron microscopyA, D, G, H, I, J——
5W9OMERS S ectodomain trimer in complex with variable domain of neutralizing antibody G4electron microscopyA, D, G, J, K, L—19 (best 0.86)
5W9OMERS S ectodomain trimer in complex with variable domain of neutralizing antibody G4electron microscopyA, D, G, J, K, L——
5W9PMERS S ectodomain trimer in complex with variable domain of neutralizing antibody G4electron microscopyJ, A, B, C, H, I—20 (best 0.86)
5W9PMERS S ectodomain trimer in complex with variable domain of neutralizing antibody G4electron microscopyJ, A, B, C, H, I——
6PZ8MERS S0 trimer in complex with variable domain of antibody G2electron microscopyA, E, INAG18 (best 0.86)
6PZ8MERS S0 trimer in complex with variable domain of antibody G2electron microscopyA, E, INAG—

Ligands

  • NAG · 2-acetamido-2-deoxy-beta-D-glucopyranose · in 6 records

Elsewhere

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.